Rituximab

About

Therapy type: Immunotherapy

Therapy strategy: CD20 inhibition

Mappings

NCI Thesaurus: Rituximab (ncit:C1702)

RxNorm: rituximab (rxcui:121191, omop:1314273)

SNOMED: Rituximab (sctid:386919002, omop:4299850)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organization(s) Biomarker(s) Cancer type Therapy(ies)
FDA (1) HSE (4) CD20 + Non-Hodgkin Lymphoma Rituximab
FDA (1) HSE (2) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Prednisolone, Rituximab, Vincristine
EMA (1) FDA (1) HSE (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine
FDA (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Fludarabine, Mitoxantrone, Rituximab
FDA (2) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Burkitt Lymphoma Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Mature B-Cell Neoplasms Cyclophosphamide, Doxorubicin, Prednisone, Rituximab, Vincristine
FDA (1) CD20 + Chronic Lymphocytic Leukemia Cyclophosphamide, Fludarabine, Rituximab
EMA (1) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine
EMA (1) CD20 + Diffuse Large B-Cell Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Non-Hodgkin Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Burkitt Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Idelalisib, Rituximab
EMA (1) HSE (1) TP53 somatic variants Chronic Lymphocytic Leukemia Idelalisib, Rituximab
EMA (1) HSE (1) 17p deletion Chronic Lymphocytic Leukemia Idelalisib, Rituximab
HSE (1) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Non-Hodgkin Lymphoma Carboplatin, Etoposide, Ifosfamide, Rituximab
HSE (2) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vinorelbine
HSE (1) CD20 + Diffuse Large B-Cell Lymphoma Gemcitabine, Oxaliplatin, Rituximab
HSE (1) CD20 + Non-Hodgkin Lymphoma Gemcitabine, Oxaliplatin, Rituximab
HSE (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Chlorambucil, Mitoxantrone, Prednisolone, Rituximab
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Interferon Alpha, Prednisolone, Rituximab
HSE (4) CD20 + Follicular Lymphoma Rituximab